Terms: = Thyroid cancer AND CHIC2, BTL, 26511, Q9UKJ5 AND Diagnosis
5 results:
1. [Role of Claudin-1 on diagnostic cut-off value and multiple tests in patients with papillary thyroid carcinoma].
Hou WD; Ding HX; Li HM; Wang JH; Liu YF
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2233-2237. PubMed ID: 34333937
[No Abstract] [Full Text] [Related]
2. DNA Methylation-Based Method to Differentiate Malignant from Benign thyroid Lesions.
Barros-Filho MC; Dos Reis MB; Beltrami CM; de Mello JBH; Marchi FA; Kuasne H; Drigo SA; de Andrade VP; Saieg MA; Pinto CAL; Kowalski LP; Rogatto SR
Thyroid; 2019 Sep; 29(9):1244-1254. PubMed ID: 31328658
[No Abstract] [Full Text] [Related]
3. A panel of four genes accurately differentiates benign from malignant thyroid nodules.
Wang QX; Chen ED; Cai YF; Li Q; Jin YX; Jin WX; Wang YH; Zheng ZC; Xue L; Wang OC; Zhang XH
J Exp Clin Cancer Res; 2016 Oct; 35(1):169. PubMed ID: 27793213
[TBL] [Abstract] [Full Text] [Related]
4. The cytological diagnosis of a 'benign thyroid lesion': is it a real safe diagnosis for the patient?
Rossi ED; Bizzarro T; Fadda G; Pontecorvi A; Bernet V; Nassar A
Cytopathology; 2016 Jun; 27(3):168-75. PubMed ID: 26388423
[TBL] [Abstract] [Full Text] [Related]
5. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary thyroid Carcinoma.
Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
[TBL] [Abstract] [Full Text] [Related]
